Premier Alternatives

Seneca Therapeutics

Blue Bell, PA · Founded 2018 · Privately Held (backing)

Developer of cell-based therapies designed to offer therapeutics and vaccines for solid cancer. Seneca Therapeutics is based in Blue Bell, PA and was founded in 2018. It was valued at $51 million at its later-stage round in Jul 2025, the last priced event on record. It has raised $25.2 million across 5 recorded rounds; the latest was a $1.6 million seed round in Dec 2024.

PMV mark · valuation
$51.0M
Oct 2026
Priced at
its later-stage round
Jul 2025
Total raised
$25.2M
Last round
Seed Round
Dec 2024

Seneca Therapeutics key facts

as of Oct 2026
  • Developer of cell-based therapies designed to offer therapeutics and vaccines for solid cancer.
  • Seneca Therapeutics is valued at approximately $51.0M as of Oct 2026, set at its later-stage round, Jul 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $25.2M across 5 recorded rounds; the latest was Seed Round ($1.6M) in Dec 2024.
  • Notable investors include Keiretsu Forum, Denniston Family Office, Accelerator Venture Partners, Broad Street Angels, Charmides Capital — 14 tracked in total.
  • Seneca Therapeutics has filed 9 Form Ds with the SEC since 2019, most recently Feb 2025 ($1.6M sold to 68 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$51.0M

Valued at $51.0M at its later-stage round, Jul 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Seneca Therapeutics with a free account
  • ·The complete investor list: 14 names
  • ·Watch Seneca Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Seneca Therapeutics funding rounds

5 rounds
Dec 2024Seed Round$1.6MSEC filing▮
Mar 2021Early Stage VC$7.7MSEC filing▮
Jun 2020Seed Round$501KSEC filing▮
Nov 2019Seed Round$820KSEC filing▮
May 2019Seed Round$380KSEC filing▮
Full funding history →

Seneca Therapeutics valuation

Seneca Therapeutics was valued at $51 million at its later-stage round in Jul 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Seneca Therapeutics raised?

Seneca Therapeutics has raised $25.2 million in total; 5 of its rounds are on record, from 2019 on. The largest on record was an $820,000 seed round in Nov 2019; the most recent was a $1.6 million seed round in Dec 2024.

Seneca Therapeutics has filed 9 Form Ds with the SEC since 2019, most recently in Feb 2025 ($1.6 million sold to 68 investors).

Seneca Therapeutics investors

14 investors are on record for Seneca Therapeutics, including Keiretsu Forum, Denniston Family Office, Accelerator Venture Partners and Broad Street Angels. The seed round in Dec 2024 drew 68 investors.

About Seneca Therapeutics

Developer of cell-based therapies designed to offer therapeutics and vaccines for solid cancer. The company focuses on oncolytic immunotherapeutic candidates to synergize with immune checkpoint inhibitors and cancer vaccines to overcome tolerance, enabling patients to access advanced targeted treatments for all types of cancer.

Sector
Healthcare
HQ
Blue Bell, PA, United States
Founded
2018
Employees
10
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.